Clinical Advisory Board
In the summer of 2011, CRC Health Group established its first-ever Clinical Advisory Board (CAB), comprised of some of the country’s top industry experts, including clinicians, researchers, and professionals within the behavioral health and addiction treatment fields. The CAB is responsible for providing expert guidance and collaboration as the company develops a cutting-edge treatment delivery system that encompasses the latest innovations and research, and is led by Dr. Phil Herschman, Chief Clinical Officer for CRC Health Group.
Kathleen T. Brady MD, PhD
Dr. Kathleen Brady is a Distinguished University Professor of Psychiatry at the Medical University of South Carolina. Her many designations include: Director of the Clinical Neuroscience Division, Associate Dean of Clinical and Translational Research, Director of the South Carolina Clinical and Translational Research Institute (SCTR), Director of MUSC’s Women’s Research Center and Principal Investigator of the Southern Consortium of NIDA’s Clinical Trials Network. Dr. Brady’s research is dedicated to the study of drug and alcohol abuse/addiction and comorbid conditions such as post-traumatic stress and other anxiety disorders. Areas of expertise include addiction and comorbidity, gender and women’s issues related to addiction/stress, and hypothalamic-pituitary-adrenal axis functioning in substance-dependent individuals. Her research, which interfaces basic and clinical science, investigates the mechanistic connection between stress and substance use disorders and the translation of empirically based treatments from academic medical centers to front-line treatment settings. Having received numerous federal research grants, Dr. Brady has published over 300 peer-reviewed manuscripts. Her dedication to furthering research careers has attracted a number of junior investigators and clinicians especially in the field of addictions. She has mentored 22 individual NIH-funded faculty development awards (K-awards) and is presently involved in two institutional faculty development programs (CTSA KL2; BIRCWH).
Thomas J. Brady, MD
Dr. Thomas J. Brady is board certified in Addiction Medicine, as well as General, Child and Adolescent, and Forensic Psychiatry. He has a private practice and is also Medical Director of Villa Fairmont Mental Health Rehabilitation Center in San Leandro, CA, Medical Director of Sausal Creek Outpatient Stabilization Clinic in Oakland, CA, and is a behavioral health consultant. Dr. Brady has held numerous medical director positions in inpatient, residential, and day treatment programs. He was a Regional Medical Director for 7 years with MHN, the managed care behavioral health carve-out for Health Net, and served almost 5 years as Vice President and Chief Medical Officer for CRC Health Group. Dr. Brady received an MBA in 2002. Currently he serves on the Executive Council of the California Society of Addiction Medicine, the Northern California Psychiatric Society, and is President of the Northern California Regional Organization of Child and Adolescent Psychiatry.
Lee T. Feldman
Lee T. Feldman is currently Co-Chair & Chief Scientific Officer for Integrya, and Executive Director and Member of the Managing Board of the Integrya not-for-profit affiliate, The Institutes for Human Security. Although his graduate studies were in immunochemistry and physics, Lee began working with the U.S. Department of Defense in 1973 on novel radar suppression technologies. His science policy work began in 1977 with the Defense Intelligence Agency where he served as Chief Scientist for the U.S. Indications and Warning Intelligence Task Force. This work led to Feldman’s development of the High Integrity Policymaking Methodology (HIP), a process and toolset that helps decision-makers apply quantitative fact-finding methods to integrate the scientific, technical, and ethical aspects of policymaking. A particular emphasis of Lee’s work is on methods for evaluating the integrity of the foundation information used in a policymaking process with a focus on quantifying uncertainty and increasing appreciation of risks that derive from the unexpected and unknown. As a scientific and policy consultant, Lee has applied the HIP methodology to policy issues in healthcare, pharmaceutical and biological technologies, biodefense policy, emerging infectious disease policy, emerging and developing market econometrics, communications technology, defense and intelligence systems, national security policy, banking and finance, international intellectual property and global trade policy, and strategy development related to environmental policy, developing world relations, and global food, nutrition and obesity issues.
Marc J. Fishman, MD
Dr. Marc Fishman is board certified in addiction psychiatry and addiction medicine. He is a member of the Psychiatry faculty of the Johns Hopkins University School of Medicine, and Medical Director of Maryland Treatment Centers, a regional behavioral health care provider which includes Mountain Manor Treatment Center in Baltimore for adolescents, Mountain Manor Treatment Center in Emmitsburg MD for adults, as well as several other inpatient and outpatient programs. In that role he has been involved in development and implementation of innovative programming in addiction and co-occurring disorder treatment. His clinical specialties include treatment of drug-involved adolescents, co-occurring addiction and psychiatric disorders, opioid dependence in adolescents and adults, and addiction with co-morbid pain. His academic work has focused on models of care and treatment outcomes in adolescent addictions. He has been principal investigator for several CSAT funded projects to improve and evaluate adolescent treatment, and has been a collaborator with other investigators in several NIDA sponsored research projects. He is the author of numerous articles and book chapters on addiction treatment, and lectures widely on a variety of topics including adolescent treatment, placement and treatment matching strategies. Dr. Fishman served as a co-editor for the most recent edition of the American Society of Addiction Medicine’s (ASAM) Patient Placement Criteria (PPC 2-R), and served as the chief editor for the recently published ASAM PPC Supplement on Pharmacotherapies for Alcohol Use Disorders. He is the chair of the Treatment Criteria Committee and the Adolescent Committee for ASAM. He is currently serving a term as the President of the Maryland Society of Addiction Medicine.
Michael T. Flaherty, PhD
Dr. Michael Flaherty is a clinical psychologist with more than 30 years’ experience in the prevention, intervention, treatment, research, and policy development related to substance use, addiction and recovery. Prior to founding IRETA in 1999 and becoming the Principle Investigator of its SAMHSA/CSAT funded Northeast ATTC, Dr. Flaherty was the Vice President of the St. Francis Health System and Director of its Institute for Psychiatry and Addiction Services, the largest such facility in Pennsylvania. In 1983 while at St. Francis, he presented his work as the opening statement before a Joint U.S. House and Senate Committee on Aging on Drug Use and Misuse in Older Americans. He has authored and overseen over 20 Federal and Foundational grants and numerous articles and books on topics ranging from pregnancy and addiction to the chronic disease understanding of addiction; how recovery based models of care support wellness and recovery and building a unified vision for recovery in America. He has five times in the past two years been an invited consultant to the White House and Office of National Drug Control and Policy and serves on numerous key advisory groups such as the Washington Circle for Quality Improvement, the SAMHSA funded Annapolis Coalition on Workforce Development, the ONDCP Synergy Group for Screening and Brief Intervention in the Addictions, and the Betty Ford Institute Consensus Panel on Recovery. He currently chairs the PA DOH/DPW D/A Coalition, conducts a national course on Patient Safety and Risk Management in Opioid Care for SAMHSA/CSAT, has been a contributing author to the SAMHSA/CSAT TIP 43 Guidelines on Opioid Care, and is the Principle author of IRETA’s 2010 PRIMER on Recovery Focused Methadone Treatment. He leads projects on the importance of recovery focused (precision) care while developing a broader, competent workforce though proven models of technology transfer. Dr. Flaherty is a retired U.S. Navy Captain with 27 years of Active and Reserve service including decorations for Desert Shield and Desert Storm. Dr. Flaherty recently retired with 27 years’ service in the U. S. Naval Reserve. Upon his retirement, he was awarded the distinguished Naval Meritorious Service Medal for his service in Bosnia, Desert Shield and Desert Storm.
Norman G. Hoffmann, PhD
Dr. Norman Hoffmann is a clinical psychologist who has evaluated behavioral health programs and provided consultations for over 30 years. He has worked with private organizations and governmental agencies in a variety of countries. Dr. Hoffmann served on an accreditation panel for the British Home Office and currently does accreditation reviews for EATA. He has developed a variety of assessments instruments used throughout the United States, as well as in Canada, Sweden, Norway, and the United Kingdom. Dr. Hoffmann has held faculty appointments at the University of Texas Medical Branch, University of Minnesota and Brown University. Currently he is President of Evince Clinical Assessments and adjunct professor of psychology at Western Carolina University.
General Barry R. McCaffrey
General Barry R. McCaffrey is President of his own consulting firm based in Arlington, Virginia, BR McCaffrey Associates. He serves as a national security and terrorism analyst for NBC News. General McCaffrey served as the Bradley Distinguished Professor of International Security Studies from January 2001 to May 2005; and then as an Adjunct Professor of International Security Studies from May 2005 to December 2010 at the United States Military Academy at West Point, NY. General McCaffrey graduated from Phillips Academy in Andover, Massachusetts and the U.S. Military Academy at West Point. He holds a Master of Arts degree in civil government from American University. He attended the Harvard University National Security Program as well as the Business School Executive Education Program. General McCaffrey is a member Phi Kappa Phi, a national honor society dedicated to the recognition and promotion of academic excellence in all disciplines. In May 2010, he was honored as a Distinguished Graduate by the West Point Association of Graduates at the United States Military Academy. He has been elected to the Board of Directors of CRC Health Corporation and the Atlantic Council of the United States. He is also: a member of the Council on Foreign Relations; an Associate of the Inter-American Dialogue; Chairman of the Vietnam Veterans Memorial Education Center Advisory Board; and a member of the Board of Advisors of the National Infantry Foundation, as well as the National Armor & Cavalry Heritage Foundation. General McCaffrey has had a long association with the Phoenix House Foundation, a non-profit dedicated to drug and alcohol abuse treatment, prevention and therapy. General McCaffrey stepped down as the Director of the White House Office of National Drug Control Policy (ONDCP) in January 2001. He was confirmed to the position by unanimous vote of the U.S. Senate in February 1996 and served as a member of the President’s Cabinet and the National Security Council for drug-related issues. As ONDCP Director, he coordinated the $19 billion federal drug control budget and developed the U.S. National Drug Control Strategy. Prior to confirmation as the National Drug Policy Director, General McCaffrey served as the Commander-in-Chief of the U.S. Armed Forces Southern Command coordinating national security operations in Latin America. During his military career, he served overseas for thirteen years and completed four combat tours. At retirement from active duty, he was the most highly decorated four-star general in the U.S. Army. He twice received the Distinguished Service Cross, the nation’s second highest medal for valor. He was also awarded two Silver Stars and received three Purple Heart medals for wounds sustained in combat. General McCaffrey served as the assistant to General Colin Powell and supported the Chairman as the JCS advisor to the Secretary of State and the U.S. Ambassador to the United Nations.
Cardwell C. Nuckols, MA, PhD
Dr. Cardwell C. Nuckols has been described as “one of the most influential clinical and spiritual trainers in North America.” Dr. Nuckols’ passion and mission is to assist in the integration of emerging scientific research with traditional spiritual and self-help knowledge. Dr. Nuckols is widely published, having authored more than 60 journal articles, 30 books and workbooks, 50 DVDs, CDs and videos, and 25 audiotape series. His latest publication is a best seller entitled The Ego-Less SELF: Achieving Peace and Tranquility Beyond All Understanding. He is the author of the book Healing an Angry Heart (HCI) and video “Chalk Talk on Drugs with Father Martin” (Kelly Productions). Two of the audio tape and DVD series- “Discovery To Recovery” and “Psychology, Spirituality and True Happiness”- are devoted to spiritual recovery and transcendence. “Neurobiology for Addiction and Mental Health Clinicians” and “The Science of Recovery: An Advanced Clinical Symposium” were released in 2010 as DVD and CD sets. A series of workbooks on “Adolescent Disruptive Behavior” and a CD on “Anger Management” has been released by Hazelden Publications as a part of their Adolescent Co-occurring Disorder Series. Dr. Nuckols other recent works include four DVDs entitled “The Evidence Based Treatment of Co-occurring Disorders,” “ A Research Based Approach To The Treatment of Anger & Aggression In Early Recovery,” “Treating Early Life Trauma Related Issues In Early Recovery From Addictive Disorders,” and “The Science Based Treatment of Addictive Disorders.” He has completed a four part video/DVD series especially designed for alcoholics and addicts in criminal justice and other treatment settings entitled “Breaking the Chains of Addiction; Using Science to Aid Recovery” and has expanded “Breaking the Chains” with a two DVD/video series on “Overcoming Anger and Aggression” and “Overcoming Early Life Trauma and Neglect.” For over 35 years, he has served the healthcare industry in multiple capacities as a clinician, supervisor, program director and hospital administrator. He currently serves as an advisor to Quantum Immunologics, Inc. a pharmaceutical research company devoted to new technologies for treating cancer. Dr. Nuckols has consulted and trained with Labor Assistance Professionals (LAP), Employee Assistance Professionals Association (EAPA), The Central Labor Council (AFL-CIO), United Auto Workers, Stouffers, Boeing, DuPont, General Motors, Bechtel-Bettis, Ford Motor Company, United Airlines and other industries in the area of enhancing productivity. He served as a trainer and consultant to the Federal Bureau of Investigation (FBI), federal court systems, and branches of the armed forces specializing in the areas of antisociality, violence, and trauma.
David Powell, PhD
Dr. David Powell is President of the International Center for Health Concerns, Inc., and the Clinical Supervision Institute and has trained for the past 34 years on clinical supervision and other topics in 50 states and 87 countries. His nine books and over 150 articles on health care and substance abuse are major texts in the field and his book, Clinical Supervision in Alcohol and Drug Abuse Counseling (2004) is considered the primary book on the subject in the substance abuse field. He was the chair and lead author of the Center for Substance Abuse Treatment, Treatment Improvement Protocol #52 on clinical supervision. He serves on the editorial board of five journals, including The Clinical Supervisor, and The Addiction Treatment Quarterly. He holds four master’s degrees in psychology, counseling, Islamic Studies, and medical ethics. He was a resident graduate at Harvard University and holds a doctoral degree in counseling and psychology. He served on advisory boards of Harvard Medical School and Johns Hopkins University and taught at Princeton and Yale Universities. Dr. Powell served as Assistant Clinical Professor of Psychiatry at Yale University School of Medicine and Senior Advisory for Yale University Behavioral Health Program, Department of Psychiatry. He has also served on the Board of Directors for the Asia Pacific Certification Board and the Middle East Certification Board. In 2009 he was given the President’s Award by the National Association of Addiction Professionals for his lifetime contribution to the addictions field. Dr.
Powell has been in the counseling field since 1965 and is a certified clinical supervisor in the alcohol and drug abuse and in sex therapy fields. He is a licensed alcohol and drug abuse counselor, licensed marriage and family therapist, and Diplomat in the International Academy of Behavioral Medicine and Psychotherapy. He is one of a hundred persons in the US that began the EAP movement in 1972 and started in 1972 the first state EAP for New Jersey and 55,000 state employees and 110,000 municipal employees. He was a founding member of the Employee Assistance Professionals Association.
Ian A. Shaffer, MD, MMM, CPE
Dr. Ian Shaffer is President of Behavioral Health Management Solutions, LLC, a consulting team that supports organizations in their efforts to deliver and manage effective and efficient mental illness and substance use disorder care. Prior to this, he served as the Vice President of Behavioral Health Programs Design and Research at Health Net Federal Services and as Chief Medical Officer of MHN, a Health Net Company. In those roles, he was responsible for the clinical development of behavioral health programs for the military. At MHN, Shaffer was responsible for setting the company’s clinical policies and guidelines and ensuring clinical excellence. Dr. Shaffer oversaw MHN’s quality improvement and disease management units, and was accountable for the coordination and quality assurance of clinical care. Dr. Shaffer was the clinical leader during the initial development of the Military Family Life Consulting Program and oversaw quality and outcomes monitoring for all Military & Family Life Consultant Program services. Shaffer collaborated with his Health Net Federal Services colleagues to ensure optimal care and service delivery for TRICARE beneficiaries. Prior to joining MHN in 2003, Dr. Shaffer served as executive vice president and chief medical officer of ValueOptions and its predecessor Value Behavioral Health, a national managed behavioral health organization, working closely with several Fortune 100 companies. He is currently serving as chairman of the Association for Behavioral Health and Wellness (ABHW) (formerly the American Managed Behavioral Healthcare Association – AMBHA) for the third time. He has also served on several federal government committees, including a three-year term on the National Advisory Committee for the Center for Mental Health Services arm of SAMHSA. He remains involved in national behavioral health policy issues, including parity and autism. Dr. Shaffer, a Certified Physician Executive and a Life Fellow of the American Psychiatric Association, is board-certified in psychiatry and addiction medicine, and has received fellowship training in child psychiatry. He received his medical degree from the University of Manitoba and psychiatry and child psychiatry training at the University of Southern California. Dr. Shaffer also holds a Master’s degree in Medical Management from Tulane University.
Gerald D. Shulman, MA, MAC, FACATA
Gerald Shulman, President of Shulman & Associates, Training & Consulting in Behavioral Health for the last 17 years, is a clinical psychologist, Master Addiction Counselor and Fellow of the American College of Addiction Treatment Administrators. He has been providing treatment or clinically or administratively supervising and/or managing the delivery of care to alcoholics and drug addicts full time since 1962. He provides training and consulting in behavioral health, with an emphasis on the implementation and use of the ASAM PPC-2R, of which he is an author, providing quality treatment in a managed care environment, re-engineering treatment to be evidenced-based, assessment, outcomes-driven treatment and older adults with substance use disorders. He was an author of the ASAM Supplement on Pharmacotherapy for Alcohol Use Disorders (Lippincott) and a Workgroup Facilitator for CSAT’s TIP #26, Substance Abuse among Older Adults. He also is the clinical supervisor for the Jacksonville BRITE Project, a Screening and Brief Intervention and Referral to Treatment (SBIRT), the only SAMHSA funded effort specifically for older adults.